logo
Ontario's forest management is falling short on key sustainability test

Ontario's forest management is falling short on key sustainability test

Canada News.Net4 days ago
Share article
Print article
Forest degradation is increasingly recognized as a major global threat. Such degradation refers to the gradual erosion of a forest's ability to store carbon, support biodiversity and sustain livelihoods, including those of Indigenous Peoples.
International frameworks such as the United Nations Convention on Biological Diversity and the UN Framework Convention on Climate Change now address degradation alongside deforestation.
While tropical forests have long been the focus, attention is also turning to temperate and boreal forests, where forest management is widespread and the potential for degradation is growing.
Some scientists have argued that if forest management is designed to be "ecologically sustainable," then there should be little concern about degradation. But is this principle being upheld in practice? Our recent study in Ontario suggests otherwise.
A widely used strategy to support ecological sustainability is to emulate natural disturbances; that is, to design human-caused disturbances so they fall within the range of variation observed in nature.
The ecological theory behind this approach is that species are adapted to cope with, or even benefit from, natural disturbances. In Canada's managed boreal forests, for example, harvesting is explicitly designed to mimic natural fires, both in individual cutblocks and across the broader landscape.
In fact, this principle is enshrined in Ontario's 1994 Crown Forest Sustainability Act that states:
"The long-term health and vigour of Crown forests should be provided for by using forest practice...that emulates natural disturbances and landscape patterns..."
The ecological sustainability of forest management is not a given: it is a hypothesis, and like any hypothesis, it must be tested. Are we actually managing forests in ecologically sustainable ways, or are we witnessing gradual forest degradation?
Our study examined the state of a 7.9 million hectare area of boreal forest in northeastern Ontario from 2012 to 2021 to test whether the provincial management regime was emulating natural disturbances, as required by law, or was instead prioritizing timber harvesting.
We used three indicators:
1) The rate at which forest was disturbed (including harvesting and fire).
2) The amount of relatively old forest (greater than 100 years old).
3) Modelled habitat for two species that have been used as indicators of sustainability: America marten and boreal caribou.
Our research did not find evidence that current practices in northeastern Ontario are emulating natural disturbances across the boreal landscape. Rather, the observed disturbance patterns appear to reflect strategies primarily focused on timber harvesting priorities.
A particular risk for boreal forests is a focus on timber production and economic returns over ecological goals. Such an approach is fundamentally at odds with the idea of emulating nature.
In particular, forests older than 100 years old have high ecological value in natural systems. They keep large amounts of carbon out of the atmosphere and provide habitat for myriad species. But if one is prioritizing timber, they are viewed as wasteful because they do not produce timber as rapidly as younger forests and are often targeted for removal. In that perspective, they are labelled "decadent."
We found that the amount of forest disturbed per year was often higher than expected under natural fire regimes and, in some coniferous forest types, even exceeded the rates expected under a strategy that prioritized timber harvesting.
Relatively old forests were also much rarer than in natural landscapes: only 22 per cent of the forest in the study area was more than 100 years old compared to an average of 54 per cent in natural landscapes.
This amount was lower than even the most conservative threshold of natural variability.
Habitats for marten and caribou were similarly degraded and fragmented. Marten habitat covered just 36 per cent of the study landscape, compared to 76 per cent in a reconstructed natural landscape. For boreal caribou, habitat was even more compromised, covering only four per cent of the study area compared to 53 per cent in the natural landscape.
Strikingly, for caribou, levels of habitat disturbance - including disturbances from harvesting, fire and roads - exceeded 70 per cent of the landscape, jeopardizing the sustainability of the two caribou populations.
Surprisingly, the clearest evidence of forest management prioritizing timber occurred within zones meant explicitly to sustain caribou. Our modelling showed that such areas will contain even less caribou habitat in the future than they do today.
The Ontario government is currently revisiting its boreal management strategy - a welcome and timely development. But rather than relying solely on a virtual reality model (Boreal Forest Landscape Disturbance Simulator) to define natural landscapes as is currently the case, it is evident that policy must be grounded in empirical data from real, unmanaged forests.
Scientific research over the past several decades has identified forest management approaches that can deliver timber while also sustaining ecological services within natural bounds.
These strategies, however, rely on tools the province has yet to embrace, including longer harvest rotations, increased use of partial harvesting instead of over-relying on clearcutting, expanded areas set aside from logging, and explicit targets for amounts of forest up to 200 years of age or older.
Our findings indicate that forest degradation is already underway in the boreal forests of Ontario. Substantial changes to forest management are required to reverse this trend and safeguard the ecosystem services on which people and wildlife depend.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders
Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders

Globe and Mail

timea day ago

  • Globe and Mail

Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders

WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Tevogen ('Tevogen Bio Holdings Inc.' or 'Company') (Nasdaq: TVGN), today released a letter to stockholders. Dear Fellow Stockholders, Tevogen has rapidly evolved from a biotechnology innovator into a dynamic enterprise expanding into artificial intelligence through Our mission remains steadfast: delivering clinically impactful, economically accessible therapies by leveraging cutting-edge science and technology. Tevogen has become a recognized name for its business philosophy of social responsibility, patient affordability and cost efficiency. In under five years, we validated our proprietary ExacTcell™ platform, completed successful proof-of-concept clinical trial of the platforms first product, established drug discovery R&D center — currently in the process of establishing our own GMP cell manufacturing facility, expanded corporate infrastructure, built a robust intellectual property portfolio, and established one of the pioneering AI initiatives in the industry — assets of significant value, while maintaining 74% insider equity ownership. With the successful launch of our proprietary AI-driven PredicTcell™ platform, we've significantly enhanced target discovery efficiency. Strategic partnerships with global technology leaders, such as Microsoft and Databricks, have accelerated our progress. Recent patent filings further secure our intellectual property in AI-driven predictive modeling, positioning us at the forefront of innovation. Importantly, Tevogen Bio is well capitalized, having access to necessary funding we may require to fully execute our current growth strategy, including the accelerated development of While the sector faces significant challenges, our company continues to grow, underscoring the foundational strength of our company. We deeply appreciate your continued support as we work toward our vision of transforming healthcare through democratizing access. It feels good to be part of this growth story and am grateful to my colleagues at Tevogen for their exceptional expertise, dedication, and, above all, their compassion for others. Sincerely, Ryan Saadi, MD, MPH Founder and CEO, Tevogen Bio Recent Announcements Tevogen Highlights 74% Insider Ownership, Reinforcing Long-Term Vision Tevogen Signs Letter of Intent for New In-House Cell Therapy Manufacturing Facility Builds Alpha Version of PredicTcell Model with Microsoft and Databricks; Observes Drastic Time Reduction in Target Analysis Translating to Potential Savings of Billions in Drug Development Costs Tevogen's New Headquarters, Fully Funded by CEO, Centralizes R&D and AI Teams to Accelerate Innovation Forward-Looking Statements This press release contains certain forward-looking statements, including without limitation statements relating to: Tevogen's plans for its research and manufacturing capabilities; expectations regarding future growth; expectations regarding the healthcare and biopharmaceutical industries; and Tevogen's development of, the potential benefits of, and patient access to its product candidates for the treatment of infectious diseases and cancer. Forward-looking statements can sometimes be identified by words such as 'may,' 'could,' 'would,' 'expect,' 'anticipate,' 'possible,' 'potential,' 'goal,' 'opportunity,' 'project,' 'believe,' 'future,' and similar words and expressions or their opposites. These statements are based on management's expectations, assumptions, estimates, projections and beliefs as of the date of this press release and are subject to a number of factors that involve known and unknown risks, delays, uncertainties and other factors not under the company's control that may cause actual results, performance or achievements of the company to be materially different from the results, performance or other expectations expressed or implied by these forward-looking statements. Factors that could cause actual results, performance, or achievements to differ from those expressed or implied by forward-looking statements include, but are not limited to: that Tevogen will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; changes in the markets in which Tevogen competes, including with respect to its competitive landscape, technology evolution, or regulatory changes; changes in domestic and global general economic conditions; the risk that Tevogen may not be able to execute its growth strategies or may experience difficulties in managing its growth and expanding operations; the risk that Tevogen may not be able to develop and maintain effective internal controls; the failure to achieve Tevogen's commercialization and development plans and identify and realize additional opportunities, which may be affected by, among other things, competition, the ability of Tevogen to grow and manage growth economically and hire and retain key employees; the risk that Tevogen may fail to keep pace with rapid technological developments to provide new and innovative products and services or make substantial investments in unsuccessful new products and services; risks related to the ability to develop, license or acquire new therapeutics; the risk of regulatory lawsuits or proceedings relating to Tevogen's business; uncertainties inherent in the execution, cost, and completion of preclinical studies and clinical trials; risks related to regulatory review, approval and commercial development; risks associated with intellectual property protection; Tevogen's limited operating history; and those factors discussed or incorporated by reference in Tevogen's Annual Report on Form 10-K. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Tevogen undertakes no obligation to update any forward-looking statements, except as required by applicable law. Contacts

McGill researchers develop AI that predicts respiratory illness before symptoms show
McGill researchers develop AI that predicts respiratory illness before symptoms show

National Post

time3 days ago

  • National Post

McGill researchers develop AI that predicts respiratory illness before symptoms show

Researchers at McGill University say they developed an artificial intelligence platform that can predict when someone is about to come down with a respiratory tract infection before they start to feel sick. Article content In what researchers are calling a 'world first,' the study involved participants who wore a ring, a watch and a T-shirt, all of which were equipped with sensors that recorded their biometric data. By analyzing the data, researchers were able to accurately predict acute systemic inflammation — an early sign of a respiratory infection such as COVID-19. Article content Article content Article content Published in The Lancet Digital Health, the study says the AI platform can one day help doctors address health problems much earlier than they normally would, particularly in patients who are fragile and for whom a new infection could have serious consequences. It could also potentially reduce costs for the health-care system by preventing complications and hospitalizations. Article content Article content 'We were very interested to see if physiological data measured using wearable sensors … could be used to train an artificial intelligence system capable of detecting an infection or disease resulting from inflammation,' explained the study's lead author, Prof. Dennis Jensen of McGill University's department of kinesiology and physical education. Article content 'We wondered if we could detect early changes in physiology and, from there, predict that someone is about to get sick.' Article content Jense says the AI model his team created is the first in the world to use physiological measures — including heart rate, heart rate variability, body temperature, respiratory rate, blood pressure _ rather than symptoms, to detect a problem. Article content Article content Acute systemic inflammation is a natural defence mechanism of the body that usually resolves on its own, but it can cause serious health problems, especially in populations with pre-existing conditions. Article content Article content 'The whole idea is kind of like an iceberg,' Jensen said. 'Kind of when the ice cracks the surface, that's like when you're symptomatic, and then it's too late to really do much to treat it.' Article content During the study, McGill researchers administered a weakened flu vaccine to 55 healthy adults to simulate infection in their bodies. The subjects were monitored seven days before inoculation and five days after. Article content Participants wore a smart ring, smart watch, and a smart T-shirt simultaneously throughout the study. As well, researchers collected biomarkers of systemic inflammation using blood samples, PCR tests to detect the presence of respiratory pathogens, and a mobile app to collect symptoms reported by participants. Article content In total, more than two billion data points were collected to train machine learning algorithms. Ten different AI models were developed, but the researchers chose the model that used the least amount of data for the remainder of the project. The chosen model correctly detected nearly 90 per cent of actual positive cases and was deemed more practical for daily monitoring.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store